T-cell epitope peptide vaccines

Sherine F. Elsawa, David A. Rodeberg, Esteban Celis

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


T-cell immunotherapy is a promising treatment option for cancer. The identification of tumor antigens that are recognized by the immune system has allowed for the generation of vaccines for various malignancies. Due to the ease of manufacturing and characterizating peptide-based vaccines they have been used to stimulate antitumor T-cells. This article will review the use of peptide-based vaccines for the treatment of cancer by inducing antitumor T-lymphocyte responses.

Original languageEnglish (US)
Pages (from-to)563-575
Number of pages13
JournalExpert Review of Vaccines
Issue number5
StatePublished - Oct 1 2004
Externally publishedYes


  • Cancer
  • Peptide vaccines
  • T-cell epitopes

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'T-cell epitope peptide vaccines'. Together they form a unique fingerprint.

Cite this